Prosomnus Sleep Technologies, Inc.

Prosomnus Sleep Technologies, Inc., a self-certified small disadvantaged business manufacturer headquartered in Pleasanton, California, supplies precision oral appliance therapy devices and advanced sleep diagnostic systems to the Defense Logistics Agency Medical Supply Chain as a prime contractor under full-and-open competition, with no subcontracting activity across its entire federal footprint. The company competes exclusively on unrestricted basis—no set-asides—and operates as the sole supplier within its narrow federal customer base.

Prosomnus manufactures the ProSomnus EVO ECAT Bundle, a comprehensive sleep diagnostic and treatment system including precision oral appliance therapy devices, sleep monitoring equipment, and related medical accessories designed to diagnose and treat obstructive sleep apnea and related sleep disorders among military personnel. The company also supplies complementary components including George Gauge Kits, bite forks, and specialized medical accessories. Representative recent work includes a $27,231 delivery order awarded December 9, 2025, for the ProSomnus EVO Guided ECAT Bundle; a $55,387.50 delivery order awarded November 24, 2025, for the same bundle; and a $55,143.75 delivery order awarded November 20, 2025. Individual delivery orders typically range from under $1,000 (for accessories and small components) to approximately $60,000 (for complete bundles with monitoring equipment).

Customer concentration is absolute. Prosomnus serves only the Defense Logistics Agency Troop Support Medical division—1,577 awards representing 100 percent of the combined potential value of $48.4 million. The vendor has no secondary customer base, no other federal agencies, and no recorded subcontract positions. This single-customer posture creates both operational stability through established demand and concentration risk dependent on continued DLA procurement.

Prosomnus operates under two parent Indefinite Delivery Contracts, both awarded by DLA Troop Support Medical. The primary vehicle, IDC SPE2DE24D0008 (the current contract awarded January 31, 2024, valued at $17.5 million through January 30, 2029), has generated 514 delivery task orders valued at $3.8 million. A predecessor IDC, SPE2DE19D0002, generated 1,061 task orders valued at $4.6 million and represents historical activity. Both contracts operate under the DLA's Electronic Catalog (ECAT) II program, a $329.4 million governmentwide Indefinite Delivery/Indefinite Quantity vehicle for specialized medical supplies across Department of Defense healthcare facilities. Delivery orders under these IDCs carry fixed-price pricing with economic price adjustment clauses and are issued on an as-needed basis to support military medical readiness.

Activity has remained relatively steady. The vendor received 252 awards in 2022, 237 in 2023, 246 in 2024, 204 in 2025, and 68 awards year-to-date in 2026 (as of April 15). The high-velocity order stream reflects DLA's recurring procurement model for this specialized medical equipment class rather than growth trajectory. Combined dollars obligated to date are $8.4 million against the $48.4 million combined potential value—a 17 percent obligation rate—indicating that many delivery orders remain in performance or have not yet been invoiced. With the current IDC running through January 30, 2029, recompete exposure is limited to that five-year horizon.

NAICS classification is 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers), with primary PSC coding 6840 (Laboratory Equipment and Supplies). The vendor does not hold positions on GSA Schedules, GWACs, or other multi-agency vehicles; its federal footprint is confined to direct call-orders under its DLA IDC. Prosomnus operates exclusively as a prime contractor with no identified teaming relationships, sub-award activity, or supply-chain partnerships recorded in the federal award data. The company's market position within the federal space is narrowly specialized—a sole or nearly-sole-source supplier of its particular oral appliance therapy product line to military medical facilities.

ProSomnus makes next generation, precision Sleep Apnea Devices. Our goal is to enable dentists to create better treatment experiences for people suffering from Obstructive Sleep Apnea and Snoring. Utilizing our patented, FDA-cleared, advanced technologies, ProSomnus Sleep Apnea and Snoring Devices are effective, comfortable, safe and easy.